Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,898 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).
Shitara K, Doi T, Nagano O, Imamura CK, Ozeki T, Ishii Y, Tsuchihashi K, Takahashi S, Nakajima TE, Hironaka S, Fukutani M, Hasegawa H, Nomura S, Sato A, Einaga Y, Kuwata T, Saya H, Ohtsu A. Shitara K, et al. Among authors: hasegawa h. Gastric Cancer. 2017 Mar;20(2):341-349. doi: 10.1007/s10120-016-0610-8. Epub 2016 Apr 7. Gastric Cancer. 2017. PMID: 27055559
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine.
Ikeda M, Sato A, Mochizuki N, Toyosaki K, Miyoshi C, Fujioka R, Mitsunaga S, Ohno I, Hashimoto Y, Takahashi H, Hasegawa H, Nomura S, Takahashi R, Yomoda S, Tsuchihara K, Kishino S, Esumi H. Ikeda M, et al. Among authors: hasegawa h. Cancer Sci. 2016 Dec;107(12):1818-1824. doi: 10.1111/cas.13086. Epub 2016 Dec 19. Cancer Sci. 2016. PMID: 27685612 Free PMC article. Clinical Trial.
Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407).
Shitara K, Doi T, Nagano O, Fukutani M, Hasegawa H, Nomura S, Sato A, Kuwata T, Asai K, Einaga Y, Tsuchihashi K, Suina K, Maeda Y, Saya H, Ohtsu A. Shitara K, et al. Among authors: hasegawa h. Gastric Cancer. 2017 Nov;20(6):1004-1009. doi: 10.1007/s10120-017-0720-y. Epub 2017 May 2. Gastric Cancer. 2017. PMID: 28466360 Clinical Trial.
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.
Sakamoto Y, Bando H, Nakamura Y, Hasegawa H, Kuwaki T, Okamoto W, Taniguchi H, Aoyagi Y, Miki I, Uchigata H, Kuramoto N, Fuse N, Yoshino T, Ohtsu A. Sakamoto Y, et al. Among authors: hasegawa h. Clin Colorectal Cancer. 2023 Mar;22(1):45-52. doi: 10.1016/j.clcc.2022.10.003. Epub 2022 Oct 22. Clin Colorectal Cancer. 2023. PMID: 36376197
Myringoplasty: A comparison of inlay and underlay techniques.
Sugimoto H, Tamori A, Hatano M, Hasegawa H, Yoshizaki T. Sugimoto H, et al. Among authors: hasegawa h. J Otol. 2024 Apr;19(2):72-76. doi: 10.1016/j.joto.2024.04.004. Epub 2024 Oct 19. J Otol. 2024. PMID: 39720113 Free PMC article.
3,898 results